TriLipix Approval Strengthens Abbott’s Cholesterol Franchise
FDA approval of Abbott's next-generation fenofibrate TriLipix (fenofibric acid) reinforces the drug maker's position in the lucrative but maturing cholesterol market
FDA approval of Abbott's next-generation fenofibrate TriLipix (fenofibric acid) reinforces the drug maker's position in the lucrative but maturing cholesterol market